Back

Artificial intelligence–enabled electrocardiography as a pre-treatment predictor of chemotherapy-related cardiac dysfunction

30 August 2026 (14:42 - 14:54)
Organised by: Logo
Congress Presentation Part of: Predicting and preventing cancer therapy–related cardiac dysfunction: from artificial intelligence to cardiometabolic protection Cardio-Oncology ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Min Sung Lee

Sejong General Hospital, Bucheon (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail
Clonal hematopoiesis of indeterminate potential (CHIP) is associated with increased risk of diastolic dysfunction in a cardio-oncology cohort
Mr J. Singh (US)
Abstract Slides Video
Presentation thumbnail
GLP-1 receptor agonists for anthracycline-associated cardiac outcomes: first meta-analytic evaluation in propensity-matched cohorts
Mr A. Chauhan (IN)
Abstract Slides Video
Presentation thumbnail
Stratification of cancer-therapy related cardiac dysfunction: a validated prediction tool to identify low risk patients.
Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides

Access the full session

Session thumbnail
Predicting and preventing cancer therapy–related cardiac dysfunction: from artificial intelligence to cardiometabolic protection
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 14:42 CET
You may be interested in
thumbnail
Congress Presentation
Artificial intelligence applied to electrocardiographic images for the risk stratification of cancer therapeutics-related cardiac dysfunction
2 September 2024
thumbnail
Congress Presentation
Baseline left atrial reservoir strain predicts subclinical left ventricular dysfunction in breast cancer patients undergoing chemotherapy
29 August 2026
thumbnail
Congress Presentation
Decoding chemotherapy-related cardiac dysfunction prediction: left ventricular strain imaging or HFA-ICOS score?
30 August 2025
thumbnail
Congress Session
Harnessing innovation to mitigate cardiovascular risk in patients with cancer
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources